The cell and gene therapy CROs market is anticipated to grow at an annualized rate of 18% by 2035



Characterized by high prevalence rate of rare and genetic disorders, and rise in demand for effective novel ATMPs, the cell and gene therapy contract research industry is likely to witness evolutionary advancements, in the coming years.

Press Release

Amazon Music Disney Promo

Roots Analysis has announced the addition of Cell and Gene Therapy CRO Market , 2022-2035” report to its list of offerings.


In order to mitigate the challenges associated with the cell and gene therapies research and development, around 50-60% of the developers prefer to outsource their operations to contract research organizations (CROs), which claim to have the required expertise and experience to leverage their capabilities and yield cost savings opportunities. The aforementioned challenges are believed to be the key factors for driving the outsourcing of research operations to a cell and gene therapy CRO , which claim to be well-aware of the nuances of advanced therapy medicinal products (ATMP) design and development, as well as cell and gene therapy manufacturing process.

To request a sample copy / brochure of this report, please visit


For additional details, please visit  or email [email protected]


You may also be interested in the following titles:

  1. Gene Therapy Market: (5TH Edition) Industry Trends and Global Forecasts, 2022-2035
  2. RNA Sequencing Services Market: Industry Trends and Global Forecasts, 2022-2035


About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.



Ben Johnson

+1 (415) 800 3415

[email protected]